These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8780825)

  • 1. Acute thrombocytopenia secondary to the administration of the peptidomimetic HIV protease inhibitor MK-639(L735524).
    Stein DS; Dunn H; Drusano GL
    AIDS; 1996 Jun; 10(6):678-80. PubMed ID: 8780825
    [No Abstract]   [Full Text] [Related]  

  • 2. Lopinavir/ritonavir- and indinavir-induced thrombocytopenia in a patient with HIV infection.
    Colebunders R; De Schacht C; Vanwolleghem T; Callens S
    Int J Infect Dis; 2004 Sep; 8(5):315-6. PubMed ID: 15325601
    [No Abstract]   [Full Text] [Related]  

  • 3. Indinavir and thrombocytopenia.
    Durand JM
    AIDS; 1999 Jan; 13(1):148-9. PubMed ID: 10207566
    [No Abstract]   [Full Text] [Related]  

  • 4. Indinavir-induced thrombocytopenia.
    Camino N; Núñez M; Blanco F; González-Requena D; González-Lahoz J; Soriano V
    AIDS Patient Care STDS; 2003 Mar; 17(3):103-4. PubMed ID: 12724005
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute respiratory failure associated with the human immunodeficiency virus (HIV) protease inhibitor indinavir in an HIV-infected patient.
    Dieleman JP; in 't Veld B; Borleffs JC; Schreij G
    Clin Infect Dis; 1998 Apr; 26(4):1012-3. PubMed ID: 9564505
    [No Abstract]   [Full Text] [Related]  

  • 6. Indinavir use: associated reversible hair loss and mood disturbance.
    Harry TC; Matthews M; Salvary I
    Int J STD AIDS; 2000 Jul; 11(7):474-6. PubMed ID: 10919491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A side effect of protease inhibitors.
    Teitel J
    CMAJ; 1998 May; 158(9):1129-30. PubMed ID: 9597957
    [No Abstract]   [Full Text] [Related]  

  • 8. Portal vein thrombosis in patients receiving indinavir, an HIV protease inhibitor.
    Carr A; Brown D; Cooper DA
    AIDS; 1997 Nov; 11(13):1657-8. PubMed ID: 9365776
    [No Abstract]   [Full Text] [Related]  

  • 9. Epidural lipomatosis secondary to indinavir in an HIV-positive patient.
    Cersósimo MG; Lasala B; Folgar S; Micheli F
    Clin Neuropharmacol; 2002; 25(1):51-4. PubMed ID: 11852297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteosclerosis and periostal new bone formation during indinavir therapy.
    Begovac J; Bayer K; Krpan D; Kusec V
    AIDS; 2002 Mar; 16(5):803-4. PubMed ID: 11964544
    [No Abstract]   [Full Text] [Related]  

  • 11. Paronychia in association with indinavir treatment.
    Colson AE; Sax PE; Keller MJ; Turk BK; Pettus PT; Platt R; Choo PW
    Clin Infect Dis; 2001 Jan; 32(1):140-3. PubMed ID: 11118393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Reversibility of severe hyperlipemia secondary to indinavir with micronized phenofibrate].
    de Luis DA; Aller R; Rachiller P; Ignacio Tortosa J
    Med Clin (Barc); 1999 Nov; 113(18):716-7. PubMed ID: 10650577
    [No Abstract]   [Full Text] [Related]  

  • 13. Ketoacidosis associated with protease inhibitor therapy.
    Besson C; Jubault V; Viard JP; Pialoux G
    AIDS; 1998 Jul; 12(11):1399-400. PubMed ID: 9708427
    [No Abstract]   [Full Text] [Related]  

  • 14. Type 2 diabetes in association with HIV-1 protease inhibitors in HIV-infected patients.
    Chronister CL; Gurwood AS
    J Am Optom Assoc; 1998 Nov; 69(11):695-8. PubMed ID: 9844321
    [No Abstract]   [Full Text] [Related]  

  • 15. "Buffalo hump" in HIV-1 infection.
    De Luca A; Murri R; Damiano F; Ammassari A; Antinori A
    Lancet; 1998 Jul; 352(9124):320. PubMed ID: 9690433
    [No Abstract]   [Full Text] [Related]  

  • 16. Severe hypertension and renal atrophy associated with indinavir.
    Cattelan AM; Trevenzoli M; Naso A; Meneghetti F; Cadrobbi P
    Clin Infect Dis; 2000 Mar; 30(3):619-21. PubMed ID: 10722466
    [No Abstract]   [Full Text] [Related]  

  • 17. Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease.
    Race EM; Adelson-Mitty J; Kriegel GR; Barlam TF; Reimann KA; Letvin NL; Japour AJ
    Lancet; 1998 Jan; 351(9098):252-5. PubMed ID: 9457095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic ketoacidosis in an HIV patient: a new mechanism of HIV protease inhibitor-induced glucose intolerance.
    Kan VL; Nylen ES
    AIDS; 1999 Oct; 13(14):1987-9. PubMed ID: 10513665
    [No Abstract]   [Full Text] [Related]  

  • 19. Stevens-Johnson syndrome caused by indinavir.
    Teira R; Zubero Z; Muñoz J; Baraia-Etxaburu J; Santamaria JM
    Scand J Infect Dis; 1998; 30(6):634-5. PubMed ID: 10225405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of pravastatin for the treatment of HIV-1 protease inhibitor-associated hyperlipidaemia: a pilot study.
    Baldini F; Di Giambenedetto S; Cingolani A; Murri R; Ammassari A; De Luca A
    AIDS; 2000 Jul; 14(11):1660-2. PubMed ID: 10983656
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.